- Family PracticeYou can seek cancer treatment at a large hospital network or you can go with a private practice. At ICI what we offer is the best of both worlds. We offer the same if not better state of the art technology, cutting edge treatments and service that you find in major hospitals but in a family practice environment that is more manageable, friendlier and takes care of you holistically.
- ColonoscopyColonoscopy should then be repeated periodically because such patients are at a higher than average risk of developing colorectal cancer. Adenomatous polyps are thought to require more than 5 years of growth before becoming clinically significant; for that reason colonoscopy does not have to be repeated more frequently than every 3 years for the great majority of patients.
- Constipation
- Erectile Dysfunction
- Urinary IncontinenceSurgery: The most common curative operation for prostate cancer is called radical prostatectomy and involves removal of the entire prostate along with the adjacent glands called the seminal vesicles. Radical prostatectomy has a small but definite risk for subsequent urinary incontinence, and sexual impotence (ED: erectile dysfunction) even in the most experienced surgical hands.
- Diarrhea
- Bladder Cancer
- Ovarian Cancer
- Cervical CancerShe is fluent in both English and Spanish. Gynecologic malignancies treated include cervical cancer, endometrial cancer, vaginal cancer and vulvar cancer. She has extensive experience in brachytherapy. She was trained in CyberKnife radiosurgery technology in 2007 and she received her gamma knife radiosurgical training at the University of Pittsburgh in 2012. She has given many lectures both locally and abroad, in English and Spanish. She has published multiple articles in peer- reviewed journals mostly in the field of head and neck cancer.
- Colon CancerColon cancer screening is beneficial at detecting precancerous changes and small early tumors in the large intestine and rectum. For adults who are at average risk of colon and rectal cancer, it is recommended to begin screening at age 50. Adults who are classified at higher risk may begin screening earlier at the recommendation of their doctor. Remember that even if you are not experiencing symptoms of colon or rectal cancer, you should always follow your doctor’s screening recommendations, including...
- Prostate CancerProstate Cancer is the 2nd most common cancer in males but the good news is that in the US, the outlook for men diagnosed with prostate cancer is better than ever. Because most prostate cancers are found early, while the tumor is still localized, the five-year survival rate is over than 90% if they are treated appropriately.
- Cancer CareRadiation oncologists may focus their practice on a specific disease site, however due to advances in the specialty, additional training may be required to keep up with high standards that cancer care demands.
- Lung CancerLung cancer is the leading cause of cancer-related death in the USA, but early diagnosis and radiation treatment can help. At the Innovative Cancer Institute (CI) we provide you with the most advanced treatment options to achieve local control of the disease and in some cases, total eradication
- Diabetes Care
- UltrasoundThe Gleason Score is an exam based on the pathologic examination of prostatic tissue obtained either from study of the prostate removed at surgery or more commonly from study of small core of tissue obtained from a needle biopsy of the prostate in patient suspected of having prostate cancer. This biopsy is usually done in patients who have a palpable nodule on rectal exam or a high PSA level. Multiple samples of prostatic tissue are obtained using a core needle biopsy under local anesthesia via a Trans-Rectal approach with Ultrasound (US) guidance (TRUS).
- MRIThe diagnostic imaging study of choice is MRI of the spine. An MRI can show parts of the vertebrae compromised by the tumor as well as help display intraspinal extradural masses compressing the spinal cord.
- RadiologyDr. Amendola has received Fellowships from the American Society of Radiation Oncology (ASTRO), from the American College of Radiation Oncology (ACRO) and from The American College of Radiology (ACR).
- X-Rays
- Computed TomographyDiagnosis starts by taking family history and reviewing symptoms, followed by a physical and neurological exam. The doctor may then recommend a CT scan or MRI, and or an MRA or Angiogram. The doctor may also recommend a biopsy in some cases.
- ChemotherapyThe most common cancer treatment options provided by doctors and oncologists are surgery or chemotherapy, two quite traditional and invasive forms of treatment.
- Radiation TherapyApr 30, 2020 | Cancer Treatment, Radiation Therapy IN 2020 THE AMERICAN CANCER SOCIETY PREDICTS THERE WILL BE OVER 1.8 MILLION NEW CANCER CASES. CURRENTLY 1 MILLION COVID CASES AS OF APRIL 28TH, 2020. HOW IS THE MEDICAL COMMUNITY RECONCILING THE NEED FOR CONTINUED CANCER TREATMENTS AND DIAGNOSES DURING THIS DIFFICULT...
- Radiation OncologyDr. Allie Garcia-Serra completed her residency training at the University of Florida where she became an expert in head and neck cancer treatment. Subsequent to this she ran the radiation oncology gynecologic oncology program for over 10 years at Baptist Hospital of South Florida and later at Miami Cancer Institute.
- Skin CancerSkin cancer is caused by exposure to ultraviolet rays (UV rays) mainly from the sun and from artificial sources such as in tanning beds. We see the most cases In Florida due the long strong sunlight hours and the older retired population. Heightened risk factors include: fair skin complexion, blond hair, blue eyes, work outdoors, chronic skin ulcers and immune depression such as in HIV infection or in patients with organ transplants on anti-rejection treatment.
- LesionsOccult blood in the stool is found in 5% of the patients with these polyps. The probability of an adenomatous polyp to become cancerous depends on the gross appearance of the lesion, its histology and its size. The likelihood that any polyp contains cancer is relative to the size of the polyp, being negligible (<2%) in lesions smaller than 1.5 cm, intermediate (2-10%) in lesions from 1.5-2.5 cm and substantial (>10%) in lesions larger than 2.5 cm in size.